1497 related articles for article (PubMed ID: 34375505)
1. Persistent endotheliopathy in the pathogenesis of long COVID syndrome.
Fogarty H; Townsend L; Morrin H; Ahmad A; Comerford C; Karampini E; Englert H; Byrne M; Bergin C; O'Sullivan JM; Martin-Loeches I; Nadarajan P; Bannan C; Mallon PW; Curley GF; Preston RJS; Rehill AM; McGonagle D; Ni Cheallaigh C; Baker RI; Renné T; Ward SE; O'Donnell JS;
J Thromb Haemost; 2021 Oct; 19(10):2546-2553. PubMed ID: 34375505
[TBL] [Abstract][Full Text] [Related]
2. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction.
Fogarty H; Ward SE; Townsend L; Karampini E; Elliott S; Conlon N; Dunne J; Kiersey R; Naughton A; Gardiner M; Byrne M; Bergin C; O'Sullivan JM; Martin-Loeches I; Nadarajan P; Bannan C; Mallon PW; Curley GF; Preston RJS; Rehill AM; Baker RI; Cheallaigh CN; O'Donnell JS;
J Thromb Haemost; 2022 Oct; 20(10):2429-2438. PubMed ID: 35875995
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long-term outcomes in COVID-19 patients.
Fan BE; Wong SW; Sum CLL; Lim GH; Leung BP; Tan CW; Ramanathan K; Dalan R; Cheung C; Lim XR; Sadasiv MS; Lye DC; Young BE; Yap ES; Chia YW;
Am J Hematol; 2022 Jul; 97(7):915-923. PubMed ID: 35477923
[TBL] [Abstract][Full Text] [Related]
5. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.
McConnell MJ; Kawaguchi N; Kondo R; Sonzogni A; Licini L; Valle C; Bonaffini PA; Sironi S; Alessio MG; Previtali G; Seghezzi M; Zhang X; Lee AI; Pine AB; Chun HJ; Zhang X; Fernandez-Hernando C; Qing H; Wang A; Price C; Sun Z; Utsumi T; Hwa J; Strazzabosco M; Iwakiri Y
J Hepatol; 2021 Sep; 75(3):647-658. PubMed ID: 33991637
[TBL] [Abstract][Full Text] [Related]
6. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
[TBL] [Abstract][Full Text] [Related]
7. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis.
Prasannan N; Heightman M; Hillman T; Wall E; Bell R; Kessler A; Neave L; Doyle A; Devaraj A; Singh D; Dehbi HM; Scully M
Blood Adv; 2022 Jul; 6(13):4041-4048. PubMed ID: 35543533
[TBL] [Abstract][Full Text] [Related]
8. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
[TBL] [Abstract][Full Text] [Related]
9. The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
Mancini I; Baronciani L; Artoni A; Colpani P; Biganzoli M; Cozzi G; Novembrino C; Boscolo Anzoletti M; De Zan V; Pagliari MT; Gualtierotti R; Aliberti S; Panigada M; Grasselli G; Blasi F; Peyvandi F
J Thromb Haemost; 2021 Feb; 19(2):513-521. PubMed ID: 33230904
[TBL] [Abstract][Full Text] [Related]
10. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response.
Townsend L; Fogarty H; Dyer A; Martin-Loeches I; Bannan C; Nadarajan P; Bergin C; O'Farrelly C; Conlon N; Bourke NM; Ward SE; Byrne M; Ryan K; O'Connell N; O'Sullivan JM; Ni Cheallaigh C; O'Donnell JS
J Thromb Haemost; 2021 Apr; 19(4):1064-1070. PubMed ID: 33587810
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Pagliari MT; Rosendaal FR; Ahmadinejad M; Badiee Z; Baghaipour MR; Baronciani L; Benítez Hidalgo O; Bodó I; Budde U; Castaman G; Eshghi P; Goudemand J; Karimi M; Keikhaei B; Lassila R; Leebeek FWG; Lopez Fernandez MF; Mannucci PM; Marino R; Oldenburg J; Peake I; Santoro C; Schneppenheim R; Tiede A; Toogeh G; Tosetto A; Trossaert M; Yadegari H; Zetterberg EMK; Peyvandi F; Federici AB; Eikenboom J
J Thromb Haemost; 2022 May; 20(5):1106-1114. PubMed ID: 35092343
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection.
Francischetti IMB; Toomer K; Zhang Y; Jani J; Siddiqui Z; Brotman DJ; Hooper JE; Kickler TS
EClinicalMedicine; 2021 Sep; 39():101069. PubMed ID: 34377969
[TBL] [Abstract][Full Text] [Related]
13. Extended coagulation profile of children with Long Covid: a prospective study.
Di Gennaro L; Valentini P; Sorrentino S; Ferretti MA; De Candia E; Basso M; Lancellotti S; De Cristofaro R; De Rose C; Mariani F; Morello R; Lazzareschi I; Sigfrid L; Munblit D; Buonsenso D
Sci Rep; 2022 Nov; 12(1):18392. PubMed ID: 36319840
[TBL] [Abstract][Full Text] [Related]
14. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628764
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19.
Karampini E; Fogarty H; Elliott S; Morrin H; Bergin C; O'Sullivan JM; Byrne M; Martin-Loeches I; Mallon PW; Curley GF; Glavey S; Baker RI; Lavin M; Preston RJS; Cheallaigh CN; Ward SE; O'Donnell JS
Res Pract Thromb Haemost; 2023 Feb; 7(2):100085. PubMed ID: 36817284
[TBL] [Abstract][Full Text] [Related]
17. VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients.
Philippe A; Günther S; Rancic J; Cavagna P; Renaud B; Gendron N; Mousseaux E; Hua-Huy T; Reverdito G; Planquette B; Sanchez O; Gaussem P; Salmon D; Diehl JL; Smadja DM
Angiogenesis; 2024 Feb; 27(1):51-66. PubMed ID: 37526809
[TBL] [Abstract][Full Text] [Related]
18. NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel.
Krinsky N; Sizikov S; Nissim S; Dror A; Sas A; Prinz H; Pri-Or E; Perek S; Raz-Pasteur A; Lejbkowicz I; Cohen-Matsliah SI; Almog R; Chen N; Kurd R; Jarjou'i A; Rokach A; Ben-Chetrit E; Schroeder A; Caulin AF; Yost CC; Schiffman JD; Goldfeder M; Martinod K
J Thromb Haemost; 2023 Sep; 21(9):2569-2584. PubMed ID: 37054916
[TBL] [Abstract][Full Text] [Related]
19. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome.
Constantinescu-Bercu A; Kessler A; de Groot R; Dragunaite B; Heightman M; Hillman T; Price LC; Brennan E; Sivera R; Vanhoorelbeke K; Singh D; Scully M
J Thromb Haemost; 2023 Jan; 21(1):94-100. PubMed ID: 36695401
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.
Henry BM; Benoit SW; de Oliveira MHS; Lippi G; Favaloro EJ; Benoit JL
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):129-136. PubMed ID: 33270980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
